Baselake Partners, LP 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 5:17 pm Unchanged | 2026-05-11 | 13G | KEZAR LIFE SCIENCES INC NE KZR | Baselake Partners, LP | 391,862 0.000% | 0 (Unchanged) | Filing |
| 2026-04-06 9:28 pm Purchase | 2026-03-30 | 13G | KEZAR LIFE SCIENCES INC NE KZR | Baselake Partners, LP | 391,862 5.300% | 391,862 (New Position) | Filing |